- Home
- U.S.
- World
- Business
- Markets
- Tech
- Personal Finance
- Life & Style
- Opinion
- Careers
- Real Estate
- Small Business
- Asia
- Europe
- Earnings
- Economy
- Health
- Law
- Autos
- Management
- Media & Marketing
-
Pharmaceutical & Biotech
- Accounting
- Advertising
- Airlines
- Banking
- Chemicals
- Computer Hardware
- Computer Software
- Consumer Products
- Defense & Aerospace
- Energy
- Broadcasting & Entertainment
- Financial Services & Insurance
- Food & Tobacco
- Hospitality
- Industrial Goods & Services
- Marketing & Strategy
- Media Agencies
- Metals & Mining
- Paper & Forest Products
- Pharmaceutical & Biotech
- Real Estate
- Retail
- Semiconductors
- Transportation
- Utilities
- Columns & Blogs
-
Subscriber Content Read Preview
Lilly Nears Zyprexa Settlement
Eli Lilly is nearing a settlement with federal prosecutors over alleged improper marketing of the antipsychotic drug Zyprexa.
-
Subscriber Content Read Preview
![[Glaxo's Emails on Avandia Reveal Concern]](https://webarchive.library.unt.edu/eot2008/20090116013258im_/http://s.wsj.net/public/resources/images/OB-CY425_avandi_A_20090114103026.jpg)
Glaxo's Avandia Emails Reveal Concern
Glaxo's internal emails indicate the company's own data was reflecting a study, which linked its diabetes treatment Avandia to heart-attack risk.
-
Subscriber Content Read Preview
Elan Launches a Strategic Review
Elan is seeking new funds and has launched a strategic review that could lead to a merger or the sale of the Irish drug maker.
-
Subscriber Content Read Preview
![[pfizer plans job cuts]](https://webarchive.library.unt.edu/eot2008/20090116013258im_/http://s.wsj.net/public/resources/images/MK-AT892_PFIZER_A_20090113214628.jpg)
Pfizer to Lay Off Researchers
Pfizer is laying off up to 800 researchers as the pharmaceutical industry faces pressure to cut spending.
-
Subscriber Content Read Preview
Bristol in Development Deal
Bristol-Myers will team with ZymoGenetics to develop a hepatitis C treatment, in a deal that could bring ZymoGenetics more than $1 billion.
-
Subscriber Content Read Preview
Roche Says Genentech Bid on Track
-
Subscriber Content Read Preview
Abbott to Buy Advanced Medical Optics
-
Subscriber Content Read Preview
ZymoGenetics in Deal With Bristol
-
Subscriber Content Read Preview
Merck's Gardasil Hits Snag
-
Investor Prospects Look Grim
-
More
Latest Pharmaceuticals & Biotech Headlines
-
UPDATE: Blackstone Exec Charged In Insider Trading Case
-
Blackstone Exec Charged Criminally In Insider Trading Case
-
CVS Caremark Raises Dividend 11% Despite Weak 2009 View >CVS
-
CVS Caremark Shares Gain On Pilot-Program Data
-
ING To Cut 750 Jobs In US, Citing Economic Conditions
-
UPDATE:Rite Aid To Pay $5M In Penalties, Agrees To DEA Plan
-
Rite Aid To Pay $5M In Penalties, Agrees To DEA Plan >RAD
-
Express Scripts CEO Backs View, Criticizes 'Retail Model'
-
SXC Health Not Feeling Pricing Pressure: CEO Thierer >SXCI
-
Stock Rating Reiterations: APWR ANF ALDN AOB AHR
-
More Headlines »
More Industries
Subscriber Content
-
Accounting
-
Advertising
-
Airlines
-
Autos
-
Banking
-
Chemicals
-
Computer Hardware
-
Computer Software
-
Consumer Products
-
Defense & Aerospace
-
Energy
-
Entertainment
-
Financial Services & Insurance
-
Food & Tobacco
-
Health
-
Hospitality
-
Industrial Goods & Services
-
Internet & Online
-
Law
-
Marketing & Strategy
-
Media
-
Media & Marketing
-
Metals & Mining
-
Paper & Forest Products
-
Pharmaceutical & Biotech
-
Real Estate
-
Retailing
-
Semiconductors
-
Telecommunications
-
Transportation
-
Utilities
Research Pharmaceutical & Biotech
View an interactive map that shows you how stocks in the Pharmaceuticals & Biotech sector are doing today, at a glance.
Get in-depth research on Pharmaceuticals & Biotech companies, including complete news and financials, earnings estimates and more.
-
Search recent Pharmaceuticals & Biotech articles for the following word(s):
Show all Pharmaceuticals & Biotech articles
Ask a Question
Ask a question about anything you choose, and let readers from the Journal Community answer it.
- *Required
Top Groups in Biotech
-
Pharmaceuticaland biotech industries group
Everything under the pharma and biotech sun--from new products to pricing policy to executive changes
-
MedTech
This group is focused on both Medical device manufacturers and Pharmaceutical developers. It will serve as a clearinghouse for information dissemination and business opportunities for its members.
-
Pharmaceutical & Biotech Professionals
A group for pharmaceutical & biotech professionals worldwide to meet and discuss matters important to them and their professions.
Partner Center
An Advertising FeatureInside the Wall Street Journal Digital Network
MarketWatch
- Japanese machinery orders fall by most in 21 years
- Peter Brimelow: Stocks' slide doesn't spook Slothower
- David Weidner's Writing on the Wall: Add Bernie "The Smirk" Madoff to the list of supercriminals
- Therese Poletti's Tech Tales: Seagate loses its straight-talking CEO amid recession
- Satyam audit reports not to be relied on: Price Waterhouse
Barron's
All Things Digital
SmartMoney
-
back to top
-
Help & Information Center:
-
About:
-
WSJ.com:
-
Tools & Formats:
-
Digital Network- WSJ.com
- Marketwatch.com
- Barrons.com
- AllThingsD.com
- FiLife.com
- BigCharts.com
- Virtual Stock Exchange
- WSJ Asia
- WSJ Europe
Foreign language editions:
- WSJ Chinese
- WSJ Portuguese
- WSJ Spanish
Hello
Your question to the Journal Community Your comments on articles will show your real name and not a username.Why?
Create a Journal Community profile to avoid this message in the future. (As a member you agree to use your real name when participating in the Journal Community)